biotricity Establishes Board of Advisors
Recognized health and medicare policy expert John Rother and participatory medicine pioneer Dr. Danny Sands to help guide clinical-grade biometric device manufacturer leadership team
biotricity, inc. (OTCQB: BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has established its board of advisors comprised of policy leader and former AARP executive John Rother and healthcare informatics professional Dr. Danny Sands. This team of experts will provide non-binding strategic advice to biotricity as it continues to develop its next generation wearable devices.
“Wearable technology is rapidly increasing in popularity, and developers are continuing to find new and innovative ways to put it to good use,” said John Rother, President and CEO of the National Coalition on Health Care and biotricity Advisor. “biotricity’s innovative solutions have the potential to ease the growing financial burden chronic diseases have on the healthcare system. I look forward to providing guidance and to helping the company achieve their goal of revolutionizing how healthcare practitioners and individuals manage their health and wellness goals.”
Dr. Danny Sands, a consultant, thought leader, and primary care physician, commented, “biotricity’s R&D focuses on the preventive healthcare market with a vision of putting health management into the hands of the individual, empowering the self-management of both critical and chronic conditions. As a medical technology company, biotricity is committed to improving healthcare by developing medical-grade solutions that aid chronic disease prevention and management. The company and its executives are an impressive team, and I look forward to helping them establish clear policy positions and advocacy strategies as they develop and bring their medically relevant devices to market.” biotricity’s new board of advisors will provide the company with timely insight and expert advice from industry authorities who have a deep understanding of medical device technology and the policies needed to bring innovative products to market.
Advisory board members include:
John Rother, JD – Mr. Rother is President and CEO of the National Coalition on Health Care, America’s oldest and most diverse group working to achieve comprehensive health system change. Prior to joining the Coalition in 2011, Rother worked at AARP for over 27 years as the Executive Vice President for Policy, Strategy, and International Affairs where he led the development of AARP’s policy positions and advocacy strategies. Under his leadership, AARP engaged in public policy research and analysis, public education, and advocacy on health and retirement issues at the federal, state and international levels. Rother wrote numerous articles and was a frequent speaker on health, retirement security, the federal budget, and the boomer generation.
Prior to that, Rother was Staff Director and Chief Counsel for the U.S. Senate Special Committee on Aging under the direction of Chairman John Heinz and served as Special Counsel for Labor and Health to U.S. Senator Jacob Javits. He has consistently been named as one of the most powerful people in Healthcare and in 2010 received the Robert Ball Award for Outstanding Achievements in Social Insurance from the National Academy of Social Insurance for “lifetime advocacy to strengthen Social Security and Medicare.”
Daniel Sands, MD, MPH – Dr. Sands is passionate about healthcare transformation, non-visit based care, collaboration in healthcare, and participatory medicine. He spent six years at Cisco, as chief medical informatics officer, where he provided both internal and external health IT leadership and helped key customers with business and clinical transformation using IT. Sands’ prior position was chief medical officer for Zix Corporation, a leader in secure e-mail and e-prescribing. Sands also spent 13 years at Beth Israel Deaconess Medical Center in Boston, where he developed and implemented numerous systems to improve clinical care delivery and patient engagement.
He has earned degrees from Brown University, Ohio State University and the Harvard School of Public Health, and trained at Boston City Hospital and Boston’s Beth Israel Hospital. Sands currently holds an academic appointment at Harvard Medical School and maintains a primary care practice in which he makes extensive use of health IT. He works as a consultant for a variety of innovative companies. Sands is the recipient of numerous health IT awards, has been elected to fellowship in both the American College of Physicians and the American College of Medical Informatics, and is a founder and co-chair of the board of the Society for Participatory Medicine. In 2009, he was recognized by HealthLeaders Magazine as one of “20 People Who Make Healthcare Better.
“Our advisory board members are uniquely qualified to help direct us, as we continue to develop innovative, next generation wearables,” said Waqaas Al-Siddiq, founder, president and CEO of biotricity.
“Dr. Sands will be instrumental in ensuring we continue to develop solutions that are optimized for individuals yet are capable of transmitting clinical-grade, scientifically accurate and reliable data. As one of the world’s most respected and admired health and social security policy pioneers, I am thrilled to welcome John to the board and look forward to tapping into his public policy research and analysis, public education, and health advocacy experience.”